84 related articles for article (PubMed ID: 8540348)
41. Analysis of autodegradation sites of thermolysin and enhancement of its thermostability by modifying Leu155 at an autodegradation site.
Matsumiya Y; Nishikawa K; Aoshima H; Inouye K; Kubo M
J Biochem; 2004 Apr; 135(4):547-53. PubMed ID: 15115781
[TBL] [Abstract][Full Text] [Related]
42. Fluctuating partially native-like topologies in the acid denatured ensemble of autolysis resistant HIV-1 protease.
Rout MK; Hosur RV
Arch Biochem Biophys; 2009 Feb; 482(1-2):33-41. PubMed ID: 19100236
[TBL] [Abstract][Full Text] [Related]
43. Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.
Babé LM; Rosé J; Craik CS
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10069-73. PubMed ID: 7479728
[TBL] [Abstract][Full Text] [Related]
44. Investigating the stereochemistry of binding to HIV-1 protease with inhibitors containing isomers of 4-amino-3-hydroxy-5-phenylpentanoic acid.
Raju B; Deshpande MS
Biochem Biophys Res Commun; 1991 Oct; 180(1):187-90. PubMed ID: 1930215
[TBL] [Abstract][Full Text] [Related]
45. HIV-1 RT enhances the activity of a tethered dimer of HIV-1 proteinase.
Goobar-Larsson L; Larsson PT; Debouck C; Towler EM
Biochem Biophys Res Commun; 1996 Mar; 220(1):203-7. PubMed ID: 8602845
[TBL] [Abstract][Full Text] [Related]
46. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
[TBL] [Abstract][Full Text] [Related]
47. Cloning, expression and purification of a recombinant poly-histidine-linked HIV-1 protease.
Leuthardt A; Roesel JL
FEBS Lett; 1993 Jul; 326(1-3):275-80. PubMed ID: 8325379
[TBL] [Abstract][Full Text] [Related]
48. Triterpenes as potential dimerization inhibitors of HIV-1 protease.
Quéré L; Wenger T; Schramm HJ
Biochem Biophys Res Commun; 1996 Oct; 227(2):484-8. PubMed ID: 8967903
[TBL] [Abstract][Full Text] [Related]
49. Stability and activity of human immunodeficiency virus protease: comparison of the natural dimer with a homologous, single-chain tethered dimer.
Cheng YS; Yin FH; Foundling S; Blomstrom D; Kettner CA
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9660-4. PubMed ID: 2263618
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive mutagenesis of HIV-1 protease: a computational geometry approach.
Masso M; Vaisman II
Biochem Biophys Res Commun; 2003 May; 305(2):322-6. PubMed ID: 12745077
[TBL] [Abstract][Full Text] [Related]
51. HIV-1 protease: structure, dynamics, and inhibition.
Louis JM; Ishima R; Torchia DA; Weber IT
Adv Pharmacol; 2007; 55():261-98. PubMed ID: 17586318
[No Abstract] [Full Text] [Related]
52. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.
Tözsér J; Zahuczky G; Bagossi P; Louis JM; Copeland TD; Oroszlan S; Harrison RW; Weber IT
Eur J Biochem; 2000 Oct; 267(20):6287-95. PubMed ID: 11012683
[TBL] [Abstract][Full Text] [Related]
53. X-ray structure of a tethered dimer for HIV-1 protease.
Bhat TN; Baldwin ET; Liu B; Cheng YS; Erickson JW
Adv Exp Med Biol; 1995; 362():439-44. PubMed ID: 8540354
[No Abstract] [Full Text] [Related]
54. Interaction of mutant forms of the HIV-1 protease with substrate and inhibitors.
Darke PL; Kohl NE; Hanobik MG; Leu CT; Vacca JP; Guare JP; Heimbach JC; Dixon RA
Adv Exp Med Biol; 1991; 306():483-7. PubMed ID: 1812746
[No Abstract] [Full Text] [Related]
55. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases.
Lin YC; Beck Z; Morris GM; Olson AJ; Elder JH
J Virol; 2003 Jun; 77(12):6589-600. PubMed ID: 12767979
[TBL] [Abstract][Full Text] [Related]
56. Computational mutagenesis studies of protein structure-function correlations.
Masso M; Lu Z; Vaisman II
Proteins; 2006 Jul; 64(1):234-45. PubMed ID: 16617425
[TBL] [Abstract][Full Text] [Related]
57. Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme function.
Chauhan J; Chen SE; Fenstermacher KJ; Naser-Tavakolian A; Reingewertz T; Salmo R; Lee C; Williams E; Raje M; Sundberg E; DeStefano JJ; Freire E; Fletcher S
Bioorg Med Chem; 2015 Nov; 23(21):7095-109. PubMed ID: 26474665
[TBL] [Abstract][Full Text] [Related]
58. Mechanical effects on the kinetics of the HIV proteinase deactivation.
Kuzmic P; Peranteau AG; García-Echeverría G; Rich DH
Biochem Biophys Res Commun; 1996 Apr; 221(2):313-7. PubMed ID: 8619852
[TBL] [Abstract][Full Text] [Related]
59. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
Strisovsky K; Tessmer U; Langner J; Konvalinka J; Kräusslich HG
Protein Sci; 2000 Sep; 9(9):1631-41. PubMed ID: 11045610
[TBL] [Abstract][Full Text] [Related]
60. Determining the 3D structure of HIV-1 protease.
Kent S; Marshall GR; Wlodawer A
Science; 2000 Jun; 288(5471):1590. PubMed ID: 10858137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
